Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:02 PM
Ignite Modification Date:
2025-12-24 @ 5:02 PM
NCT ID:
NCT04601350
Eligibility Criteria:
Inclusion Criteria:
* ASAⅠ-Ⅱ
* Patients undergoing elective surgery under general anesthesia.
* Age, sex, and weight were not limited.
Exclusion Criteria:
* Allergic or contraindication to remimazolam/midazolam/remifentanil;
* Abnormal liver and kidney function; Alcohol abuse;
* Long-term use of sedative, analgesic or anxiolytic drugs;
* Hearing and language communication disorders;
* Complicated with severe cardiovascular lesions or neurological diseases.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT04601350
Study Brief:
Protocol Section:
NCT04601350